Results 151 to 160 of about 857,892 (246)
Pertussis Immunisation—Additional Factors Governing the Potency for Mice of Phase I Vaccines [PDF]
David F. Gray
openalex +1 more source
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
M. Mulligan +24 more
semanticscholar +1 more source
A reprogrammed (RP) phage‐based nanovaccine platform has been developed that allows single‐step assembly with precise control over adjuvanticity, antigen density, and nanoparticle size. By enhancing TLR9 activation and neoantigen display, this platform enables a potent personalized vaccine targeting tumor‐specific neoantigens. When combined with immune
Shengnan Huang +10 more
wiley +1 more source
Concentration and Purification of Influenza Virus for the Preparation of Vaccines [PDF]
A. R. Taylor +4 more
openalex +1 more source
Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery
This perspective introduces an artificial intelligence (AI)‐driven nanoarchitectonics framework for targeted drug delivery, combining database‐guided nanocarrier design, machine learning (ML)‐assisted surface engineering with a designed targeting system, and in silico modeling for dynamic optimization.
Hayeon Bae +6 more
wiley +1 more source
Studies on Chick Embryo Vaccines Against Japanese B Encephalitis [PDF]
Hilary Koprowski, Herald R. Cox
openalex +1 more source
MXene and MBene nanomaterials show significant potential in addressing critical challenges in biomedicine, applied biology, agriculture, and the environment. From a nano‐agricultural perspective, this relatively young field has witnessed emerging advances towards applications for plant‐immunoengineering, biostimulation, and controlled delivery ...
Alireza Rafieerad +3 more
wiley +1 more source
Remarks on the Results which have been Obtained by the Antityphoid Inoculations and on the Methods which have been Employed in the Preparation of the Vaccine [PDF]
Almroth Edward Wright, W. B. Leishman
openalex +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source

